The "Ultimate Triple PET": 68Ga-DOTATATE, 18F-FDG, and 18F-Fluciclovine PET/CT Findings in a Single Patient With Metastatic Abdominal Carcinoid and Prostate Cancer

Matthew Mcclenathan; Justin G. Peacock

doi:10.1097/RLU.0000000000003853

The "Ultimate Triple PET": 68Ga-DOTATATE, 18F-FDG, and 18F-Fluciclovine PET/CT Findings in a Single Patient With Metastatic Abdominal Carcinoid and Prostate Cancer

Matthew Mcclenathan, Justin G. Peacock^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

A 71-year-old man with a history of carcinoid and prostate adenocarcinoma underwent 68Ga-DOTATATE PET/CT to evaluate new mediastinal lymphadenopathy. The scan revealed new carcinoid metastases, but the mediastinal nodes were not avid. 18F-FDG PET/CT was performed to evaluate for cardiac and mediastinal sarcoidosis, revealing a lack of cardiac sarcoidosis, but probable mediastinal sarcoidosis. 18F-Fluciclovine PET/CT was then performed for possible prostate metastases, revealing the patient's known prostate cancer. Three different PET radiopharmaceuticals revealed 3 different processes in a single patient within a 195-day period, demonstrating the power of nuclear medicine diagnostics.

Original language	English
Pages (from-to)	E161-E164
Journal	Clinical Nuclear Medicine
Volume	47
Issue number	2
DOIs	https://doi.org/10.1097/RLU.0000000000003853
State	Published - 1 Feb 2022
Externally published	Yes

Keywords

DOTATATE
FDG
fluciclovine
PET

Access to Document

10.1097/RLU.0000000000003853

Cite this

@article{2da1cfec32aa4f3a90ce54efe96f27a8,

title = "The {"}Ultimate Triple PET{"}: 68Ga-DOTATATE, 18F-FDG, and 18F-Fluciclovine PET/CT Findings in a Single Patient With Metastatic Abdominal Carcinoid and Prostate Cancer",

abstract = "A 71-year-old man with a history of carcinoid and prostate adenocarcinoma underwent 68Ga-DOTATATE PET/CT to evaluate new mediastinal lymphadenopathy. The scan revealed new carcinoid metastases, but the mediastinal nodes were not avid. 18F-FDG PET/CT was performed to evaluate for cardiac and mediastinal sarcoidosis, revealing a lack of cardiac sarcoidosis, but probable mediastinal sarcoidosis. 18F-Fluciclovine PET/CT was then performed for possible prostate metastases, revealing the patient's known prostate cancer. Three different PET radiopharmaceuticals revealed 3 different processes in a single patient within a 195-day period, demonstrating the power of nuclear medicine diagnostics.",

keywords = "DOTATATE, FDG, fluciclovine, PET",

author = "Matthew Mcclenathan and Peacock, {Justin G.}",

year = "2022",

month = feb,

day = "1",

doi = "10.1097/RLU.0000000000003853",

language = "English",

volume = "47",

pages = "E161--E164",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - The "Ultimate Triple PET"

T2 - 68Ga-DOTATATE, 18F-FDG, and 18F-Fluciclovine PET/CT Findings in a Single Patient With Metastatic Abdominal Carcinoid and Prostate Cancer

AU - Mcclenathan, Matthew

AU - Peacock, Justin G.

PY - 2022/2/1

Y1 - 2022/2/1

N2 - A 71-year-old man with a history of carcinoid and prostate adenocarcinoma underwent 68Ga-DOTATATE PET/CT to evaluate new mediastinal lymphadenopathy. The scan revealed new carcinoid metastases, but the mediastinal nodes were not avid. 18F-FDG PET/CT was performed to evaluate for cardiac and mediastinal sarcoidosis, revealing a lack of cardiac sarcoidosis, but probable mediastinal sarcoidosis. 18F-Fluciclovine PET/CT was then performed for possible prostate metastases, revealing the patient's known prostate cancer. Three different PET radiopharmaceuticals revealed 3 different processes in a single patient within a 195-day period, demonstrating the power of nuclear medicine diagnostics.

AB - A 71-year-old man with a history of carcinoid and prostate adenocarcinoma underwent 68Ga-DOTATATE PET/CT to evaluate new mediastinal lymphadenopathy. The scan revealed new carcinoid metastases, but the mediastinal nodes were not avid. 18F-FDG PET/CT was performed to evaluate for cardiac and mediastinal sarcoidosis, revealing a lack of cardiac sarcoidosis, but probable mediastinal sarcoidosis. 18F-Fluciclovine PET/CT was then performed for possible prostate metastases, revealing the patient's known prostate cancer. Three different PET radiopharmaceuticals revealed 3 different processes in a single patient within a 195-day period, demonstrating the power of nuclear medicine diagnostics.

KW - DOTATATE

KW - FDG

KW - fluciclovine

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=85123207695&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000003853

DO - 10.1097/RLU.0000000000003853

M3 - Article

C2 - 34392283

AN - SCOPUS:85123207695

SN - 0363-9762

VL - 47

SP - E161-E164

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 2

ER -